why choose us

First received: November 07, 2022

Clinical Trial: Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults

Study Status: Completed

Recruit Status: RECRUITING

Condition: Tourette Disorder

Study Type: INTERVENTIONAL


Official Title: A Multicenter, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Maintenance of Efficacy of Ecopipam in Children, Adolescents and Adults With Tourette's Dis

Brief Summary: This Phase 3 multicenter study evaluates the maintenance of efficacy, safety and tolerability of ecopipam tablets in children, adolescents and adults in the treatment of Tourette's Disorder (TD).The study includes an open-label period followed by double-blind, placebo-controlled, randomized withdrawal period.

Read more